Kalaitzidis RG - Search Results

1

Opportunistic screening for hypertension: what does it say about the true epidemiology?

Menti A, Kalpourtzi N, Gavana M, Vantarakis A, Voulgari PV, Hadjichristodoulou C, Gkaliagkousi E, Doumas M, Kalaitzidis RG, Kallistratos MS, Karakosta A, Katsi V, Krokidis X, Manios E, Marketou M, Ntineri A, Papadakis JA, Papadopoulos D, Sarafidis P, Trypsianis G, Chatzopoulos M, Chlouverakis G, Alamanos Y, Zebekakis P, Touloumi G, Stergiou GS. Menti A, et al. Among authors: kalaitzidis rg. J Hum Hypertens. 2022 Apr;36(4):364-369. doi: 10.1038/s41371-021-00532-5. Epub 2021 Apr 9. J Hum Hypertens. 2022. PMID: 33837294

2

Ambulatory blood pressure monitoring in hemodialysis patients.

Elisaf M, Pappas H, Kalaitzidis R, Katopodis K, Theodorou J, Siamopoulos KG. Elisaf M, et al. J Hum Hypertens. 1996 Sep;10 Suppl 3:S43-7. J Hum Hypertens. 1996. PMID: 8872825

3

Effectiveness and metabolic effects of perindopril and diuretics combination in primary hypertension.

Elisaf MS, Theodorou J, Pappas H, Papagalanis N, Katopodis K, Kalaitzidis R, Siamopoulos KC. Elisaf MS, et al. J Hum Hypertens. 1999 Nov;13(11):787-91. doi: 10.1038/sj.jhh.1000834. J Hum Hypertens. 1999. PMID: 10578225 Clinical Trial.

4

Effects of thiazolidinediones beyond glycaemic control.

Kalaitzidis RG, Sarafidis PA, Bakris GL. Kalaitzidis RG, et al. Curr Pharm Des. 2009;15(5):529-36. doi: 10.2174/138161209787315693. Curr Pharm Des. 2009. PMID: 19199979 Review.

5

Uncontrolled Hypertension and Oncology: Clinical Tips.

Kalaitzidis RG, Elisaf MS. Kalaitzidis RG, et al. Curr Vasc Pharmacol. 2017;16(1):23-29. doi: 10.2174/1570161115666170414121436. Curr Vasc Pharmacol. 2017. PMID: 28413967 Review.

6

Treatment of Hypertension in Chronic Kidney Disease.

Kalaitzidis RG, Elisaf MS. Kalaitzidis RG, et al. Curr Hypertens Rep. 2018 Jun 11;20(8):64. doi: 10.1007/s11906-018-0864-0. Curr Hypertens Rep. 2018. PMID: 29892833 Review.

7

The effects of nebivolol and irbesartan on postdialysis and ambulatory blood pressure in patients with intradialytic hypertension: a randomized cross-over study.

Bikos A, Loutradis C, Angeloudi E, Karpetas A, Raptis V, Kalaitzidis R, Panagoutsos S, Pasadakis P, Balaskas I, Liakopoulos V, Papagianni A, Sarafidis PA. Bikos A, et al. J Hypertens. 2019 Feb;37(2):432-442. doi: 10.1097/HJH.0000000000001891. J Hypertens. 2019. PMID: 30063644 Clinical Trial.

8

Arterial Stiffness, Cognitive Dysfunction and Adherence to Antihypertensive Agents. Is there a Link to Hypertensive Patients?

Kalaitzidis RG, Panagiotopoulou T, Stagikas D, Pappas K, Balafa O, Elisaf MS. Kalaitzidis RG, et al. Curr Vasc Pharmacol. 2020;18(4):410-417. doi: 10.2174/1570161117666190415112953. Curr Vasc Pharmacol. 2020. PMID: 30987567 Review.

9

Salt sensitivity and hypertension.

Balafa O, Kalaitzidis RG. Balafa O, et al. Among authors: kalaitzidis rg. J Hum Hypertens. 2021 Mar;35(3):184-192. doi: 10.1038/s41371-020-00407-1. Epub 2020 Aug 29. J Hum Hypertens. 2021. PMID: 32862203 Review.

10

Adherence to Treatment, Arterial Stiffness and Cognitive Function in Irbesartan- Treated Newly Diagnosed Hypertensive Patients.

Kalaitzidis RG, Balafa O, Dounousi E, Stagikas D, Tsimihodimos V. Kalaitzidis RG, et al. Curr Vasc Pharmacol. 2021;19(5):565-571. doi: 10.2174/1570161119666201120160104. Curr Vasc Pharmacol. 2021. PMID: 33222674

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page